Streptokinase in the treatment of central retinal vein occlusion. A controlled trial.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001766:Blindness / Q000209:etiology; D005260:Female; D006470:Hemorrhage / Q000150:complications; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012169:Retinal Vein; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000150:complications / Q000188:drug therapy; D014792:Visual Acuity; D014859:Warfarin / Q000627:therapeutic use
D014859:Warfarin; D006493:Heparin; D013300:Streptokinase